RESEARCH TRIANGLE PARK, N.C. – BioCryst Pharmaceuticals , Inc. (NASDAQ:), currently trading at $8.05 with…
BioCryst projects $515-$535 million in ORLADEYO sales for 2025 By Investing.com
RESEARCH TRIANGLE PARK, N.C. – BioCryst Pharmaceuticals , Inc. (NASDAQ:), currently trading at $8.05 with…